Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H. Miller
Current topics in behavioral neurosciences (2016), pp. 173-198
Closed Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Recognizing Depression from the Microbiota–Gut–Brain Axis
Shan Liang, Xiaoli Wu, Xu Hu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1592-1592
Open Access | Times Cited: 327
Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
Joshua D. Rosenblat, Roger S. McIntyre
Brain Sciences (2017) Vol. 7, Iss. 11, pp. 144-144
Open Access | Times Cited: 222
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 203
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Ronald S. Duman
F1000Research (2018) Vol. 7, pp. 659-659
Open Access | Times Cited: 177
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 164
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 155
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 998-1007
Open Access | Times Cited: 138
The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation
Larissa N. Dooley, Kate R. Kuhlman, Theodore F. Robles, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 94, pp. 219-237
Open Access | Times Cited: 139
<p>Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway</p>
Shuhan Liu, Rongjuan Guo, Fei Liu, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 859-869
Open Access | Times Cited: 97
Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
Ebrahim Haroon, Xiangchuan Chen, Zhihao Li, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 92
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
David R. Goldsmith, Mark Hyman Rapaport
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 84
Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression
Julie Lasselin, Mats Lekander, Sven Benson, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 3672-3683
Open Access | Times Cited: 78
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Qian-Qian Chen, Caroline Haikal, Wen Li, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 77
Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
Young‐Kook Kim, Oh Yoen Kim, Juhyun Song
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 71
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Emma I Kopra, Valeria Mondelli, Carmine M. Pariante, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 934-945
Open Access | Times Cited: 59
Is depression the missing link between inflammatory mediators and cancer?
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108293-108293
Closed Access | Times Cited: 43
Cancer‐related inflammation and depressive symptoms: Systematic review and meta‐analysis
Daniel C. McFarland, Meredith Doherty, T. Atkinson, et al.
Cancer (2022) Vol. 128, Iss. 13, pp. 2504-2519
Open Access | Times Cited: 41
Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study
Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 299-310
Open Access | Times Cited: 38
Immune mechanisms of depression in rheumatoid arthritis
James B. Brock, Neil Basu, Johannes C. M. Schlachetzki, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 12, pp. 790-804
Closed Access | Times Cited: 33
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Xiying Fu, Yicun Wang, Fangyi Zhao, et al.
Aging (2023)
Open Access | Times Cited: 31
How Oxidative Stress Induces Depression?
Na Ji, Mengzhu Lei, Yating Chen, et al.
ASN NEURO (2023) Vol. 15
Open Access | Times Cited: 29
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
Huiyang Liu, Xiaomei Zhang, Peng Shi, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review
Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 7, pp. 983-1016
Closed Access | Times Cited: 8
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Talar Ahmad Merza Mohammad, Tavgah Ahmed Merza Mohammad, Dyar Mudhafar Salman, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 04, pp. 205-214
Closed Access | Times Cited: 8
From air to mind: unraveling the impact of indoor pollutants on psychiatric disorders
Germán Torres, Ryia T. Subbaiah, Riya A. Sood, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top